Supply of Advate and Adynovate Imported Plasma and Recombinant Products
Expired
Federal
TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.
Awarded by National Blood Authority
$109.5M
Contract Value
Contract Details
- Reference
- CN3737775
- Jurisdiction
- Federal
- Financial Year
- FY25
- Category
- Drugs and Pharmaceutical(UNSPSC: 51000000)
Description
Supply of Advate and Adynovate Imported Plasma and Recombinant Products
Key Dates
- Publish Date
- 5 July 2024
- Effective Date
- 31 Dec 2019
- End Date
- 29 June 2025
Published fields
- Procurement method
- Limited tender
- Location
- Not published in this source
Supplier
TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.
- ABN
- 71 095 610 870
Agency
National Blood Authority
- ABN
- 87 361 602 478
Contract History
This contract has been amended 3 times.
Original Contract
Published 17 Dec 2020
$85.5M
Amendment A1
Published 5 July 2024
$52.5M
Amendment A2
Published 5 July 2024
$87.6M
Amendment A3
Current
Published 5 July 2024
$109.5M